[DRUG] YoY Annual Result on 30-Sep-2022 [#FY]

Stock
[DRUG] Bright Minds Biosciences Inc.
Announcement Date
29-Dec-2022
Financial Year
2022
Quarter
30-Sep-2022 [#FY]
Profit Trend
YoY- -78.37%
Quarter Report
DRUG's Result
DRUG's Financial Summary
View:
Show?
Annual Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 0 0 0 0 0 -
PBT -7,372 -14,965 -8,651 -480 -79 210.56%
Tax -14 223 -135 6 -0 -
NP -7,372 -15,188 -8,515 -486 -79 210.56%
Tax Rate - - - - - -
Total Cost 7,372 15,188 8,515 486 79 210.56%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -1.98 -6.15 -4.74 -0.38 -0.06 139.53%
EPS Diluted -1.98 -6.15 -4.74 -0.38 -0.06 139.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.